Budinsky A - Search Results

1

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.

Krainer M, Wolf H, Michl I, Wiltschke C, Budinsky A, Kaider A, Kratzik C, Eibl MM, Zielinski CC. Krainer M, et al. Among authors: budinsky a. Cancer. 1995 Jan 15;75(2):539-44. doi: 10.1002/1097-0142(19950115)75:2<539::aid-cncr2820750217>3.0.co;2-4. Cancer. 1995. PMID: 7529130

2

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: budinsky ac. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

3

Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.

Budinsky AC, Brodowicz T, Wiltschke C, Czerwenka K, Michl I, Krainer M, Zielinski CC. Budinsky AC, et al. Int J Cancer. 1997 Jun 11;71(6):1086-90. doi: 10.1002/(sici)1097-0215(19970611)71:6<1086::aid-ijc27>3.0.co;2-a. Int J Cancer. 1997. PMID: 9185715

4

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro.

Brodowicz T, Wiltschke C, Budinsky AC, Krainer M, Steger GG, Zielinski CC. Brodowicz T, et al. Among authors: budinsky ac. Int J Cancer. 1997 Dec 10;73(6):875-9. doi: 10.1002/(sici)1097-0215(19971210)73:6<875::aid-ijc19>3.0.co;2-3. Int J Cancer. 1997. PMID: 9399669

5

Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study Group.

Schmidinger M, Steger GG, Wenzel C, Locker GJ, Brodowicz T, Budinsky AC, Wiltschke C, Kramer G, Marberger M, Zielinski CC. Schmidinger M, et al. Among authors: budinsky ac. Cancer Immunol Immunother. 2000 Sep;49(7):395-400. doi: 10.1007/s002620000128. Cancer Immunol Immunother. 2000. PMID: 10999466 Free PMC article. Clinical Trial.

6

Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriers.

Zielinski CC, Budinsky AC, Wagner TM, Wolfram RM, Köstler WJ, Kubista M, Brodowicz T, Kubista E, Wiltschke C. Zielinski CC, et al. Breast Cancer Res Treat. 2003 Sep;81(2):99-105. doi: 10.1023/A:1025761716283. Breast Cancer Res Treat. 2003. PMID: 14572152

7

Impaired hemorheology in patients with postmastectomy lymphedema.

Djavanmard MP, Michl I, Korpan M, Fazeny B, Budinsky AC, Wiesinger E, Weinländer G, Binder M, Püspök M, Zielinski CC, Fialka V, Koppensteiner R, Marosi C. Djavanmard MP, et al. Among authors: budinsky ac. Breast Cancer Res Treat. 1996;38(3):283-8. doi: 10.1007/BF01806147. Breast Cancer Res Treat. 1996. PMID: 8739081

8

Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinoma.

Schmidinger M, Steger GG, Budinsky AC, Wenzel C, Brodowicz T, Locker GJ, Kramer G, Marberger M, Zielinski CC. Schmidinger M, et al. Among authors: budinsky ac. Anticancer Drugs. 2000 Mar;11(3):175-9. doi: 10.1097/00001813-200003000-00005. Anticancer Drugs. 2000. PMID: 10831276 Clinical Trial.

9

Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer.

Wolfram RM, Budinsky AC, Brodowicz T, Kubista M, Köstler WJ, Kichler-Lakomy C, Hellan M, Kahlhammer G, Wiltschke C, Zielinski CC. Wolfram RM, et al. Among authors: budinsky ac. Int J Cancer. 2000 Oct 15;88(2):239-44. Int J Cancer. 2000. PMID: 11004675

10

Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial.

Schmidinger M, Budinsky AC, Wenzel C, Locker GJ, Pluschnig U, Brodowicz T, Kubista E, Maca S, Zabernigg A, Ilsinger P, Seewann L, Hojas S, Blach M, Zielinski CC, Steger GG. Schmidinger M, et al. Among authors: budinsky ac. Cancer Chemother Pharmacol. 2001;47(1):57-62. doi: 10.1007/s002800000204. Cancer Chemother Pharmacol. 2001. PMID: 11221963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters